Page values for "Medroxyprogesterone"

Nav

"Medicines" values

1 row is stored for this page

Field	Field type	Value
generic	`String`	Medroxyprogesterone acetate (MPA)
brand	`String`	Provera (oral), Depo-Provera (IM contraceptive), Depo-SubQ Provera 104 (SC)
structure	`File`
classes	List of `String`, delimiter: `,`	[[:Category:Progestogens\|Progestin (synthetic progestogen)]] • [[:Category:Hormonal_contraceptives\|Hormonal contraceptive (Depo)]] • [[:Category:Sex_hormones\|Sex hormone]]
mechanism	`String`
uses	`String`	'"`UNIQ--vote-00000F1B-QINU`"', '"`UNIQ--vote-00000F1C-QINU`"', '"`UNIQ--vote-00000F1D-QINU`"', '"`UNIQ--vote-00000F1E-QINU`"', '"`UNIQ--vote-00000F1F-QINU`"'
starting_dose	`String`	Contraception: Depo-Provera 150 mg IM every 13 weeks; Depo-SubQ 104 mg SC every 12-13 weeks; oral cycling: 5-10 mg PO daily ×5-10 days for amenorrhea
preparations	`String`	2.5, 5, 10 mg oral tablets; Depo-Provera 150 mg/mL IM; Depo-SubQ Provera 104 mg/0.65 mL
fda_max	`String`	Indication-specific
pill_id	`Text`
routes	List of `String`, delimiter: `,`	Oral • IM • SC
onset	`String`	Contraceptive within 24 hours if given in first 5 days of cycle; otherwise backup for 7 days
duration	`String`	Depot IM 13 weeks (designed); often persists longer
halflife	`String`	~50 days (Depo-Provera; long depot release)'"`UNIQ--ref-00000F20-QINU`"'
bioavailability	`String`	Oral ~90%; depot IM essentially 100% over the dosing interval'"`UNIQ--ref-00000F21-QINU`"'
pregnancy	`String`	Contraindicated in known pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed\|citation needed]]]</sup>
legal	`String`	[[USLegal:Prescription only\|Rx-only]] in US. Carries a '''Boxed Warning''' for bone mineral density loss with prolonged use (≥2 years; partially reversible after discontinuation)'"`UNIQ--ref-00000F22-QINU`"'